DIRTT teams up with Healthcare Innovation Partners to deliver Constructed Clinical Enclosures
COVID-19 rates around the world are continuing to increase and many cities are preparing for the much-anticipated second wave. Facilitating safe testing and consultation options for both medical professionals and patients is an urgent issue every healthcare system is racing to manage. They want a solution that reduces the risk of exposure and, moves patients through quickly, but doesn’t sacrifice a personal connection. That’s the challenge doctors from a Massachusetts teaching hospital gave to Healthcare Innovation Partners (HIP). And that’s the solution they created in partnership with DIRTT.
Originally, HIP took inspiration from a Korean hospital that created a specialized testing enclosure. From there, they looked for a way to boost the efficiency of treatment. Once they finessed the design, HIP went looking for a manufacturing partner.
Together, DIRTT and HIP are building Constructed Clinical Enclosures (CCE).
These CCE are stand-alone units that can be deployed indoors or outdoors. They provide healthcare professionals a direct-contact but physically separated environment to test and consult patients. Just like facilities within a hospital, they can be HEPA filtered, positive or negative pressure environments, and configured to be Americans with Disabilities Act (ADA) compliant. The transparent partitions with sealed glove panels are purpose-built to maximize visibility between the provider and patient. This can improve communication and quality of care.
Return on Investment
From a provider standpoint, CCE offer a great return on investment. Because the patient is kept separate, CCE can facilitate up to a 95% reduction in the use of personal protective equipment (PPE)* as healthcare workers can choose to avoid continually changing in and out of masks, gloves and gowns. This time savings allows more patients to be processed. It also reduces material use, bringing additional cost savings.
Faster and more efficient patient treatment
When assembled on-site, CCEs are available in 14 days from order. This means patients get treatment sooner. And because they’re modular, the designs are flexible. They can expand for different treatment needs and respond to changing protocols.
In addition to the financial upside, CCEs have a noticeable human benefit. Healthcare workers can avoid the frustration that comes with continually dealing with PPE.
Depending on the application, there are multiple styles of enclosures that can be used indoors – single patient and multi-patient.
In the single configuration, the patient enters the enclosure for treatment. After testing, the enclosure can be easily cleaned before the next patient uses it.
In the multi-configuration, the healthcare provider enters the enclosure. The multi-sided structure allows the healthcare provider to treat one patient while the other panels are disinfected between use. This greatly increases the capacity for treatment.
The outdoor configurations work the same way. There’s a single entry for healthcare providers. From inside, they can tend to single or multiple patients. The enclosure is powered, climate-controlled, and weather protected.
Testing is just one way to use CCE. Purpose-built to reduce the risk of exposure, these enclosures offer a solution to capacity issues around vaccinations, treatments, and examinations. And since they are easily deployable in various environments, CCE turn almost any public facility into a screening location. More testing results means more data. Data allows us all to make informed decisions that could help keep those rising COVID-19 numbers in line.
Take a closer look at DIRTT and HIP’s Constructed Clinical Enclosures
*The CCE are a constructed facility, not a medical device. The enclosures are not to be used in lieu of PPE, but rather, together with PPE, to further reduce the risk of exposure due to direct face-to-face or skin-to-skin contact. Users must develop and approve their own infection control procedures. The CCE have not been reviewed or approved by the Food and Drug Administration or by any other agency.
DIRTT is a building process powered by technology. We use our proprietary 3D software to help design, manufacture, and install fully customized interior environments. This same software provides clients with certainty around cost, schedule, and the final outcome. With modular components and a streamlined construction process, complete interior spaces are constructed faster, cleaner, and more sustainably. The Company works with over 70 partners throughout North America. DIRTT trades on Nasdaq under the symbol “DRTT” and on the Toronto Stock Exchange under the symbol “DRT”.